Mhsn Primary Care Services Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2585 W Houghton Lake Dr, Prudenville, MI 48651 Phone: 989-366-2900 |
Mhsn Primary Care Services Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2585 W Houghton Lake Dr, Prudenville, MI 48651 Phone: 989-366-2900 |
Mhsn Primary Care Services Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2585 W Houghton Lake Dr, Prudenville, MI 48651 Phone: 989-366-2900 |
Balance Mental Health & Wellness Pc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 3386 W Houghton Lake Dr, Prudenville, MI 48651 Phone: 989-312-1800 |
Prudenville Community Health Center Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2585 W Houghton Lake Dr, Prudenville, MI 48651 Phone: 989-366-2900 |
News Archive
The Children's Hospital of Philadelphia announces the availability of proton therapy, a precise form of cancer radiation that offers potentially life-changing benefits to children with brain tumors and other solid tumors. The Hospital's Cancer Center has recently begun using proton treatment at the new Roberts Proton Therapy Center, a cutting-edge radiation oncology facility located across the street from Children's Hospital in Penn Medicine's Perelman Center for Advanced Medicine.
Pupils had 3 months to come up with solutions to a variety of high level challenges faced in the healthcare environment and UK market. The challenge encourages Key Stage 4 students to find out more about the world of engineering and technology.
A new study, published on the medRxiv* preprint server, has focused on the use of anti-nucleocapsid (N) antibody positivity as a marker of SARS-CoV-2 infection. In the present study, these antibody markers were evaluated using serological surveillance studies post-vaccination amidst circulation of variants of concern.
Work published this week in the journal Proceedings of the National Academy of Sciences shows that an enzyme inhibitor developed by Professor Bruce Hammock and colleagues at UC Davis reduced inflammation in the brains of mice born to mothers with maternal immune activation.
Health officials in the Pacific are concerned about two new strains of tuberculosis - multi drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) - both strains have been found to be resistant to the two most powerful drugs that have been used to treat tuberculosis (TB) for the past five decades.
› Verified 9 days ago